Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 161

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Plasma microbiome-modulated indole- and phenyl-derived metabolites associate with advanced atherosclerosis and postoperative outcomes

Open access
Cason, Cori A., Dolan, Kyle T., Sharma, Gaurav, Tao, Ming, Kulkarni, Rohan, Helenowski, Irene B., Doane, Brendan M., Avram, Michael J., McDermott, Mary M., Chang, Eugene B., Ozaki, C. Keith, Ho, Karen J. · 2018 · Journal of Vascular Surgery

Abstract

Objective Multiple studies have shown that gut microbes contribute to atherosclerosis, and there is mounting evidence that microbial metabolism of dietary nutrients influences pathophysiology. We hypothesized that indole- and phenyl-derived metabolites that originate solely or in part from bacterial sources would differ between patients with advanced atherosclerosis and age- and sex-matched controls without clinically apparent atherosclerosis. Methods Plasma from the advanced atherosclerosis cohort (n=100) were from patients who underwent carotid endarterectomy, leg bypass surgery, or major leg amputation for critical limb ischemia. The controls (n=22) were age- and sex-matched participants who had no peripheral arterial disease or history of stroke or myocardial infarction. Patients with chronic kidney disease were excluded. Metabolites and internal standards were measured using tandem high performance liquid chromatography and mass spectrometry. Results Plasma metabolite concentrations differed significantly between the advanced atherosclerosis and control cohorts. After adjustment for traditional atherosclerosis risk factors, indole (odds ratio [OR], .84; 95% confidence interval [CI], .75–.95; P=.004), tryptophan (OR, <.001; 95% CI, <.001–.003; P<.001), indole-3-propionic acid (OR, .27; 95% CI, .019–.91; P=.02), and indole-3-aldehyde (OR, .12; 95% CI, .014–.92; P=.04) negatively associated with advanced atherosclerosis, while the kynurenine/tryptophan ratio (OR, 61.7; 95% CI, 1.9–>999; P=.02) was positively associated. Furthermore, tryptophan and indole-3-propionic acid (Spearman coefficients 0.63 and 0.56, respectively, P<.001) correlated with the ankle-brachial index, a surrogate for overall atherosclerotic disease burden. Fourteen patients experienced a major post-operative cardiac complication within 30 days in the advanced atherosclerosis cohort, which was associated with baseline kynurenine/tryptophan ratio (P=.001) and hippuric acid (P=.03). In a multivariate analysis, only the kynurenine/tryptophan ratio remained significantly associated with a post-operative cardiac complication (OR, 44.1; 95% CI, 3.3–587.1; P=.004). Twenty patients in the advanced atherosclerosis cohort experienced a major adverse cardiac event during the follow-up period, which was associated with hippuric acid (P=.002) and the kynurenine/tryptophan ratio (P<.001). Both hippuric acid and the kynurenine/tryptophan ratio were independently associated with a major adverse cardiac event in multivariate analyses that included diabetes mellitus. Conclusions Specific microbe-derived metabolite signatures associate with advanced human atherosclerosis and post-operative cardiac complications. We suggest that these metabolites are potential novel biomarkers for atherosclerotic disease burden and that further investigation into mechanistic links between defined microbial metabolic pathways and cardiovascular disease is warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jvs.2017.09.029

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 161

Metadata

Authors
Cason, C. A., Dolan, K. T., Sharma, G., Tao, M., Kulkarni, R., Helenowski, I. B., Doane, B. M., Avram, M. J., McDermott, M. M., Chang, E. B., Ozaki, C. K., & Ho, K. J.
Venue
Journal of Vascular Surgery
Publisher
Elsevier BV
Published
2018-11
Volume
68
Issue
5
Pages
1552-1562.e7
ISSN
0741-5214 (ISSN-L)
OpenAlex
W2774273450
Cited by
161
References
15
FWCI
1.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.